News in Numbers
The European Commission, the World Health Organization, and other partners announced a €1.1bn financing partnership that will fund polio vaccination immunisation campaigns and improve health systems.
The EMA’s Committee for Medicinal Products for Human Use (CHMP) suggested seven new medicines for potential approval as part of its October 2023 meeting.
Bristol Myers Squibb will spend up to $5.8 billion through its acquisition of the cancer developer Mirati Therapeutics as it pushes to diversify its drug portfolio.
All 10 drug companies whose treatments were chosen for Medicare price negotiations by the US government have agreed to take part in the discussions in 2023 and 2024.
The US Department of Health and Human Services awarded grants of over $500 million for the clinical development of innovative next-generation vaccine and therapeutics platforms as part of Project NextGen.